Mint Tower Capital Management B.V. Iveric Bio, Inc. Transaction History
Mint Tower Capital Management B.V.
- $318 Million
- Q3 2024
A detailed history of Mint Tower Capital Management B.V. transactions in Iveric Bio, Inc. stock. As of the latest transaction made, Mint Tower Capital Management B.V. holds 20,300 shares of ISEE stock, worth $0. This represents 0.08% of its overall portfolio holdings.
Number of Shares
20,300Holding current value
$0% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ISEE
# of Institutions
7Shares Held
250KCall Options Held
40KPut Options Held
0-
Monarch Partners Asset Management LLC187KShares$01.22% of portfolio
-
Pictet Asset Management Sa Geneva 73, V825KShares$00.0% of portfolio
-
Jefferies Group LLC New York, NY19.5KShares$00.0% of portfolio
-
Aevitas Wealth Management, Inc.17.8KShares$00.22% of portfolio
-
Endurance Wealth Management, Inc.1.5KShares$00.01% of portfolio
About IVERIC bio, Inc.
- Ticker ISEE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,078,000
- Description
- IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...